$29.7 Million is the total value of Healthcare Value Capital, LLC's 17 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 16.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABBV | ABBVIE INC | $3,750,000 | +22.3% | 35,000 | 0.0% | 12.63% | +25.0% | |
| GSK | GLAXOSMITHKLINE PLCsponsored adr | $3,680,000 | -2.2% | 100,000 | 0.0% | 12.40% | -0.0% | |
| VYNE | Buy | VYNE THERAPEUTICS INC | $3,160,000 | +5.8% | 2,000,000 | +11.1% | 10.65% | +8.1% |
| GILD | GILEAD SCIENCES INC | $2,913,000 | -7.8% | 50,000 | 0.0% | 9.81% | -5.8% | |
| TYME | TYME TECHNOLOGIES INC | $2,654,000 | +24.5% | 2,175,000 | 0.0% | 8.94% | +27.3% | |
| ATRS | ANTARES PHARMA INC | $1,995,000 | +47.8% | 500,000 | 0.0% | 6.72% | +51.1% | |
| MCK | MCKESSON CORP | $1,739,000 | +16.8% | 10,000 | 0.0% | 5.86% | +19.4% | |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $1,651,000 | -53.7% | 10,000 | -60.0% | 5.56% | -52.7% |
| AMRN | Buy | AMARIN CORP PLCcall | $1,467,000 | +248.5% | 300,000 | +200.0% | 4.94% | +256.4% |
| CAH | CARDINAL HEALTH INC | $1,339,000 | +14.1% | 25,000 | 0.0% | 4.51% | +16.6% | |
| CLVS | CLOVIS ONCOLOGY INC | $1,200,000 | -17.7% | 250,000 | 0.0% | 4.04% | -15.9% | |
| MRNA | MODERNA INCput | $1,045,000 | +47.6% | 10,000 | 0.0% | 3.52% | +50.9% | |
| GNLN | GREENLANE HLDGS INCcl a | $990,000 | +76.8% | 250,000 | 0.0% | 3.34% | +80.7% | |
| VIXY | Buy | PROSHARES TR IIcall | $687,000 | +34.7% | 50,000 | +100.0% | 2.32% | +37.7% |
| NVAX | NOVAVAX INCput | $558,000 | +3.0% | 5,000 | 0.0% | 1.88% | +5.3% | |
| ADMS | ADAMAS PHARMACEUTICALS INC | $433,000 | +5.1% | 100,000 | 0.0% | 1.46% | +7.4% | |
| GMDA | New | GAMIDA CELL LTD | $420,000 | – | 50,000 | +100.0% | 1.42% | – |
| SPXU | Exit | PROSHARES TRcall | $0 | – | -100,000 | -100.0% | -2.87% | – |
| SPXU | Exit | PROSHARES TRultrapro short s | $0 | – | -250,000 | -100.0% | -7.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GILEAD SCIENCES INC | 20 | Q3 2021 | 31.3% |
| GLAXOSMITHKLINE PLC | 20 | Q3 2021 | 16.1% |
| PFIZER INC | 19 | Q3 2021 | 17.9% |
| TYME TECHNOLOGIES INC | 17 | Q3 2021 | 40.3% |
| ASTRAZENECA PLC | 14 | Q3 2021 | 12.9% |
| QUEST DIAGNOSTICS INC | 14 | Q3 2016 | 9.5% |
| CRYOLIFE INC | 13 | Q1 2017 | 6.6% |
| ANTARES PHARMA INC | 13 | Q3 2021 | 6.7% |
| AMARIN CORP PLC | 13 | Q3 2021 | 4.9% |
| CYTOKINETICS INC | 13 | Q3 2016 | 1.7% |
View Healthcare Value Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVELION THERAPEUTICS INC. | September 20, 2019 | 1,400,000 | 7.4% |
View Healthcare Value Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| SC 13D/A | 2019-09-20 |
View Healthcare Value Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.